Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Rohit Gosain: Revumenib is Now FDA Approved for R/R AML with NPM1 Mutation
Rohit Gosain/LinkedIn
Oct 27, 2025, 08:00

Rohit Gosain: Revumenib is Now FDA Approved for R/R AML with NPM1 Mutation

Rohit Gosain, Medical Director of Roswell Park Comprehensive Cancer Center, posted on LinkedIn:

“Revumenib is now FDA approved for R/R AML with NPM1 mutation (approved for KMT2A translocation previously).

– ORR 46.9%
– Response seen in all subgroups (comutations, previous HSCT, or high number of prior lines of Rx).”

Rohit Gosain: Revumenib is Now FDA Approved for R/R AML with NPM1 Mutation

Stay informed with Hemostasis Today.

FDA Headlines Health Hematology Hemostasis Hemostasis Today Medicine R/R AML w/ NPM1 Mutation Revumenib Rohit Gosain
NewsFeed